# Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion

Study · id `cardio:ct-nct06221371` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06221371](<https://clinicaltrials.gov/study/NCT06221371>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06221371

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 391 participants.

## Technical summary

Registry record NCT06221371. Randomized; single masking; primary purpose treatment. Start 2024-01-25 (actual); primary completion 2025-10-13 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 391 participants (enrolled count; ClinicalTrials.gov record NCT06221371, source copy `cardio:ctgov-nct06221371-2025-11-26`, retrieved 2026-10-26)
- Started: 2024-01-25 (actual) (ClinicalTrials.gov record NCT06221371, source copy `cardio:ctgov-nct06221371-2025-11-26`, retrieved 2026-10-26)
- Primary completion: 2025-10-13 (actual) (ClinicalTrials.gov record NCT06221371, source copy `cardio:ctgov-nct06221371-2025-11-26`, retrieved 2026-10-26)
- Completion: 2025-10-13 (actual) (ClinicalTrials.gov record NCT06221371, source copy `cardio:ctgov-nct06221371-2025-11-26`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06221371, source copy `cardio:ctgov-nct06221371-2025-11-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06221371-2025-11-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion
- Acronym: TNK-PLUS
- Condition: Ischemic Stroke, Acute
- Condition: Thrombolysis
- Condition: Endovascular Treatment
- Intervention (Drug): Tenecteplase
- Intervention (Device): direct EVT
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER
- Collaborator: Linyi People's Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Tenecteplase (`cardio:tenecteplase`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)
- Registry lists this organization as a collaborator: Linyi People's Hospital (`cardio:org-linyi-people-s-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Intravenous Tenecteplase Prior to Endovascular Treatment for Ischemic Stroke at 4.5 to 24 Hours: The TNK-PLUS Randomized Clinical Trial (`cardio:pubmed-42099212`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 22ad962136ece4c59643075fc9070317a9ca7c692ecf846c4df35e3a30621ff0
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
